Ana Batinić, Ph.D.

Ana Batinić, Ph.D., is a distinguished Master of Pharmacy and Doctor of Science (Ph.D.) in Biomedicine and Health. She successfully combines her high academic qualification with extensive practical experience, which includes long-term pharmacy management and leading the Solutions Module in a Galenic Laboratory.

Dr. Batinić is currently engaged as an External Collaborator in Pharmaceutical Toxicology at the Faculty of Pharmacy, University of Split. Her primary research focus is centered on clinical trials regarding the effect of new Cannabidiol (CBD) formulations on patients with hypertension. As an author and co-author of relevant scientific publications, Dr. Batinić possesses the in-depth knowledge necessary for expert consulting in pharmaceutical innovations and the regulatory aspects of toxicology.

She actively contributes to the international professional community by volunteering with Cochrane since 2017 and serving as a member of the Committee for International Cooperation in the Croatian Chamber of Pharmacists, thus ensuring access to the latest clinical findings and international best practices.